232 related articles for article (PubMed ID: 36941602)
1. Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma.
Liu M; Huang L; Liu Y; Yang S; Rao Y; Chen X; Nie M; Liu X
J Transl Med; 2023 Mar; 21(1):208. PubMed ID: 36941602
[TBL] [Abstract][Full Text] [Related]
2. Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer.
Cheng T; Chen P; Chen J; Deng Y; Huang C
Front Genet; 2021; 12():809600. PubMed ID: 35069702
[TBL] [Abstract][Full Text] [Related]
3. Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).
Li K; Li D; Hafez B; Bekhit MMS; Jardan YAB; Alanazi FK; Taha EI; Auda SH; Ramzan F; Jamil M
Oncol Res; 2024; 32(4):737-752. PubMed ID: 38560573
[TBL] [Abstract][Full Text] [Related]
4. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
5. The matrix metalloproteinase gene family: a significant prognostic gene lineage correlated with immune infiltrates in laryngeal squamous cell carcinoma.
Yang C; Cao H; Yang JW; Liu T; Wang JT; Wang BS
Neoplasma; 2021 Nov; 68(6):1212-1224. PubMed ID: 34585589
[TBL] [Abstract][Full Text] [Related]
6. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study.
Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M
Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571
[TBL] [Abstract][Full Text] [Related]
7. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma.
Wang T; Zhang Y; Bai J; Xue Y; Peng Q
BMC Cancer; 2021 Sep; 21(1):1068. PubMed ID: 34587931
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma.
Xu L; Yang H; Yan M; Li W
Clin Exp Med; 2023 Oct; 23(6):2065-2083. PubMed ID: 36169759
[TBL] [Abstract][Full Text] [Related]
9. A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential.
Gobin E; Bagwell K; Wagner J; Mysona D; Sandirasegarane S; Smith N; Bai S; Sharma A; Schleifer R; She JX
BMC Cancer; 2019 Jun; 19(1):581. PubMed ID: 31200666
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma.
Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X
Gene; 2022 Jun; 827():146461. PubMed ID: 35358652
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer.
Luan H; Jian L; Huang Y; Guo Y; Zhou L
Sci Rep; 2023 Oct; 13(1):17211. PubMed ID: 37821678
[TBL] [Abstract][Full Text] [Related]
12. NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment.
Chen XM; Liu YY; Tao BY; Xue XM; Zhang XX; Wang LL; Zhong H; Zhang J; Yang SM; Jiang QQ
Front Immunol; 2022; 13():975847. PubMed ID: 36091055
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of matrix metalloproteinases and their inhibitors in head and neck squamous cell carcinoma.
Zou M; Zhang C; Sun Y; Wu H; Xiao F; Gao W; Zhao F; Fan X; Wu G
Acta Oncol; 2022 Apr; 61(4):505-515. PubMed ID: 34879791
[No Abstract] [Full Text] [Related]
14. NUTF2 as a Prognostic Indicator and Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Li P; Wen X; Zhang X; Wang F; Zhang D; Shang H
Genet Test Mol Biomarkers; 2022 Dec; 26(12):553-563. PubMed ID: 36577127
[No Abstract] [Full Text] [Related]
15. Interferon Regulatory Factor Family Genes: At the Crossroads between Immunity and Head and Neck Squamous Carcinoma.
Liu S; Wang Z
Dis Markers; 2022; 2022():2561673. PubMed ID: 35664436
[TBL] [Abstract][Full Text] [Related]
16. FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.
Liang H; Zhang C; Li C; Li C; Wang Y; Lin H
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34028536
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis of the role of CXC ligands in the microenvironment of head and neck tumor.
Jing F; Wang J; Zhou L; Ning Y; Xu S; Zhu Y
Aging (Albany NY); 2021 Jul; 13(13):17789-17817. PubMed ID: 34247149
[TBL] [Abstract][Full Text] [Related]
18. TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma.
Yang Z; Li X; Li J; Su Q; Qiu Y; Zhang Z; Zhang L; Mo W
Biomed Res Int; 2020; 2020():3962146. PubMed ID: 33083464
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer.
Yu J; He Z; He X; Luo Z; Lian L; Wu B; Lan P; Chen H
Front Oncol; 2021; 11():771099. PubMed ID: 34804973
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of extracellular-matrix and inflammation related genes in oral squamous cell carcinoma.
Thakore VP; Patel KD; Vora HH; Patel PS; Jain NK
Arch Oral Biol; 2024 May; 161():105925. PubMed ID: 38442470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
